Drug Pipeline

JYB1904 Clinical Trials

Name: JYB1904 clinical trials — 4 active studies
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12

Active Studies

Recruiting

Phase 3

Top Sponsors

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-06-06	NCT07220811 Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy	Trial sites expanded: 26 -> 31 locations

Active Studies by Phase

Phase 3

Phase 2

Phase 1

Active Trials

NCT ID	Title	Condition	Status
Phase 3
NCT07402213	Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.	Chronic Spontaneous Urticaria	Not Yet Recruiting
Phase 2
NCT07220811	Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy	Ig-E Mediated Food Allergy	Recruiting
NCT07459452	Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis	Perennial Allergic Rhinitis	Not Yet Recruiting
Phase 1
NCT07513857	Trial of JYB1904 Injection in Adolescent Participants	Allergic Diseases	Not Yet Recruiting

Sponsors Running JYB1904 Trials

Jemincare (3) RAPT Therapeutics, Inc. (1)

Get alerts when JYB1904 trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.